Aclacinomycin A

CAS : 57576-44-0

Ref. 3D-AA08264

Informations sur le produit

• Nom: Aclacinomycin A
• Synonymes: Aclarubicin, 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-<span class="text-smallcaps">L</smallcap>-lyxo-hexopyranosyl]-3-(dimethylamino)-α-<smallcap>L</span>-lyxo-hexopyranosyl]oxy]-, methyl ester, (1R,2R,4S)-, 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-<span class="text-smallcaps">L</smallcap>-lyxo-hexopyranosyl]-3-(dimethylamino)-α-<smallcap>L</span>-lyxo-hexopyranosyl]oxy]-, methyl ester, [1R-(1α,2β,4β)]-, Aclacinomycin A, Streptomycesgalilaeus, Aclacur, Antibiotic 3082A, Antibiotic 77-3082A, Antibiotic MA 144A1, Jaclacin, NSC 208734, methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-({2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-(6-methyl-5-oxotetrahydro-2H-pyran-2-yl)hexopyranosyl]-3-(dimethylamino)hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate, methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[(3xi)-2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranosyl}-3-(dimethylamino)-alpha-L-threo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate, methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranosyl}-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
• CAS: 57576-44-0

Description

Dual inhibitor of topoisomerase I and II

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 811.87 g/mol
• Formule: C₄₂H₅₃NO₁₅
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder